Sexually Transmitted Diseases  >  Publications  >  Report of the Genital Herpes Prevention Consultants Meeting May 5-6, 1998

Report of the Genital Herpes Prevention Consultants Meeting May 5-6, 1998

Previous

Table of Contents

Next

7. Preparation for Immunization Strategies

Immunization strategies were not intended as a primary focus of the consultants meeting, in the belief that practical and effective vaccines against HSV were to be expected only in the relatively distant future. (The possibility was recognized that the gG2-based recombinant vaccine currently in trials sponsored by SmithKline Beecham might prove effective, but skepticism has been engendered by the failure of the Chiron Corporation’s similar vaccine.) However, there was consensus that an effective vaccine represents the best hope for a maximally effective prevention program, and promising developments in research into other vaccine candidates were raised by several consultants. Thus, there was strong consensus that it is not premature to begin to undertake studies of behavioral, patient acceptance, and other aspects of future immunization strategies to prevent genital herpes.

• CDC should promote HSV vaccine development (consensus high, priority high).
• CDC should develop a plan for vaccine use, distribution, and administration (consensus high, priority high).
• CDC should conduct or support research to assess the acceptability of vaccination strategies by populations at current or future risk (consensus high, priority high).

Previous

Table of Contents

Next